T2 Biosystems, Inc. (TTOO)
0.01
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
T2 Biosystems Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -509.7% |
| June 30, 2024 | -459.2% |
| March 31, 2024 | -656.7% |
| December 31, 2023 | -615.8% |
| September 30, 2023 | -1.05K% |
| June 30, 2023 | -323.2% |
| March 31, 2023 | -864.5% |
| December 31, 2022 | -189.9% |
| September 30, 2022 | -472.5% |
| June 30, 2022 | -305.1% |
| March 31, 2022 | -228.0% |
| December 31, 2021 | -174.0% |
| September 30, 2021 | -188.0% |
| June 30, 2021 | -186.4% |
| March 31, 2021 | -153.2% |
| December 31, 2020 | -127.2% |
| September 30, 2020 | -214.6% |
| June 30, 2020 | -418.7% |
| March 31, 2020 | -587.4% |
| December 31, 2019 | -457.5% |
| September 30, 2019 | -845.0% |
| June 30, 2019 | -867.4% |
| March 31, 2019 | -848.6% |
| Date | Value |
|---|---|
| December 31, 2018 | -845.4% |
| September 30, 2018 | -436.6% |
| June 30, 2018 | -313.5% |
| March 31, 2018 | -558.8% |
| December 31, 2017 | -1.10K% |
| September 30, 2017 | -1.27K% |
| June 30, 2017 | -1.62K% |
| March 31, 2017 | -1.56K% |
| December 31, 2016 | -1.60K% |
| September 30, 2016 | -1.18K% |
| June 30, 2016 | -1.42K% |
| March 31, 2016 | -1.22K% |
| December 31, 2015 | -1.19K% |
| September 30, 2015 | -1.11K% |
| June 30, 2015 | -1.95K% |
| March 31, 2015 | -5.65K% |
| December 31, 2014 | -7.63K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -24.15K% |
| September 30, 2013 | -5.10K% |
| June 30, 2013 | -5.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ABVC BioPharma, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Perspective Therapeutics, Inc. | -162.2K% |
| MiMedx Group, Inc. | -13.94% |
| Abbott Laboratories | 7.07% |